FZRO Stock Overview
CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CS Diagnostics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.17 |
| 52 Week High | US$6.25 |
| 52 Week Low | US$0.021 |
| Beta | 0 |
| 1 Month Change | -28.13% |
| 3 Month Change | -49.26% |
| 1 Year Change | -95.69% |
| 3 Year Change | -97.35% |
| 5 Year Change | -93.10% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| FZRO | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 1.2% |
| 1Y | -95.7% | 3.6% | 24.7% |
Return vs Industry: FZRO underperformed the US Healthcare industry which returned 3.6% over the past year.
Return vs Market: FZRO underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| FZRO volatility | |
|---|---|
| FZRO Average Weekly Movement | 111.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FZRO's share price has been volatile over the past 3 months.
Volatility Over Time: FZRO's weekly volatility (111%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Thomas Fahrhöfer | cs-diagnostics.de |
CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler.
CS Diagnostics Corp. Fundamentals Summary
| FZRO fundamental statistics | |
|---|---|
| Market cap | US$136.31k |
| Earnings (TTM) | -US$341.61k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs FZRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FZRO income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$341.61k |
| Earnings | -US$341.61k |
Last Reported Earnings
Mar 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did FZRO perform over the long term?
See historical performance and comparison